Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Methylprednisolone Acetate Injection
Status: Currently in Shortage
»Date first posted:
12/15/2021
»Therapeutic Categories: Rheumatology
Amneal Pharmaceuticals (Revised 02/09/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1) | Limited Availability | Currently Inventory available 4 to 6 weeks as per current demand. Next supply: week of 02/09/2026 | Other |
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-5) | Available | Currently product is under backorder as per current demand. Next supply: week of 02/09/2026 | |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-1) | Available | Currently Inventory available 4 to 8 Weeks as per current demand. Next supply: week of 03/16/2026 | |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-5) | Available | Currently Inventory available 2 to 4 Weeks as per current demand. Next supply: week of 02/09/2026 |
Eugia US LLC (Revised 05/05/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01) | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 55150-314-01) | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
Par Health, USA LLC (Reverified 05/01/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01) | Unavailable | Estimated recovery: TBD | Demand increase for the drug |
Pfizer Inc. (Reverified 05/08/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52) | Available | ||
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02) | Available | ||
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01) | Limited Availability | Limited Supply Available. Next Delivery: May 2026; Estimated Recovery: June 2026 | Demand increase for the drug |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03) | Limited Availability | Limited Supply Available. Next Delivery: May 2026; Estimated Recovery: June 2026; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23) | Available | ||
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01) | Available | ||
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03) | Available |
Sagent Pharmaceuticals (Reverified 04/23/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10) | Available | ||
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05) | Unavailable | Estimated availability: May 2026 | Shortage of an active ingredient |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05) | Available |